Clinical Trial Update: Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating adjuvant thalidomide therapy with chemoembolization for advanced hepatocellular carcinoma; the study status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Fudan University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: UNKNOWN